Inogen Inc (INGN) Financial Statements — Income, Balance Sheet, Cash Flow

Overview Financials Chart Business Summary Filings Ownership Valuation

Financial Statements — INGN

Balance Sheet

(in millions USD)

Metric	Q2 2026	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022	Q3 2021	Q2 2021	Q1 2021
Cash & Equivalents	87.28	93.11	106.48	103.69	118.89	105.69	97.92	107.44	124.61	167.69	164.14	209.63	223.62	213.40	241.58	238.85	220.01
Accounts Receivable	46.16	41.87	40.37	38.59	36.62	34.23	36.04	40.22	48.38	51.14	53.89	50.53	31.15	33.98	32.91	36.95	38.42
Inventory	28.63	24.99	25.08	24.31	26.27	23.32	24.05	24.60	24.02	30.74	38.82	35.73	33.50	34.08	31.79	27.23	26.39
Total Current Assets	194.14	190.67	203.72	203.12	200.71	192.55	194.79	199.19	225.27	269.22	283.15	317.78	315.45	318.12	335.83	327.57	309.68
Property, Plant & Equipment	31.78	33.69	37.33	40.17	41.10	46.60	47.02	49.27	49.53	49.20	45.94	40.63	40.42	39.33	37.07	34.03	31.05
Goodwill	10.40	10.48	10.70	10.70	9.86	10.17	9.76	9.83	9.87	32.89	32.89	32.67	32.80	32.93	33.03	33.09	33.06
Intangible Assets	27.45	28.91	32.05	33.36	31.61	33.76	33.59	32.91	34.07	--	--	53.70	55.85	58.00	62.30	64.42	66.56
Total Non-current Assets*	91.44	95.26	103.29	108.92	107.70	113.62	114.13	116.41	118.43	105.13	102.53	151.81	154.62	156.49	177.03	170.61	166.80
Total Assets	285.57	285.93	307.01	312.04	308.41	306.17	308.92	315.60	343.70	374.35	385.67	469.58	470.07	474.62	512.86	498.17	476.48
Accounts Payable	39.68	32.70	34.21	35.14	35.92	27.03	26.78	31.71	30.41	27.61	32.18	33.51	26.81	32.38	29.22	31.54	29.35
Total Current Liabilities	70.86	61.45	64.94	67.07	65.45	72.40	72.19	73.91	60.38	59.37	63.38	65.74	59.34	59.82	59.93	61.84	55.47
Total Non-current Liabilities*	39.84	41.57	44.89	45.48	45.01	48.37	49.14	49.79	52.68	40.21	41.00	53.01	54.19	56.51	62.00	65.42	64.72
Total Liabilities	110.71	103.02	109.83	112.55	110.46	120.77	121.32	123.70	113.07	99.57	104.38	118.74	113.53	116.33	121.94	127.26	120.19
Retained Earnings	(187.76)	(183.91)	(168.46)	(163.16)	(159.01)	(143.08)	(137.12)	(131.53)	(90.39)	(44.67)	(34.85)	42.11	51.62	55.06	92.15	79.97	74.87
Total Stockholder Equity	174.86	182.91	197.18	199.49	197.95	185.40	187.60	191.90	230.63	274.78	281.30	350.84	356.54	358.29	390.92	370.92	356.28

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Total Revenue	83.53	72.40	68.57	79.09	79.17	68.47	66.31	74.93	74.43	63.10	59.40	67.97	68.34	55.89	73.18	90.67	89.29	67.40	63.37	80.97
Cost of Revenue	44.95	40.18	39.36	42.93	43.47	38.08	35.50	39.59	38.32	35.24	39.94	42.71	42.03	33.96	51.75	55.89	50.66	39.50	32.19	40.44
Gross Profit	43.27	37.86	35.24	41.32	41.34	36.37	36.29	41.34	42.74	34.37	28.16	33.76	34.04	30.73	29.47	42.80	46.26	35.01	38.59	47.69
Research & Development	5.87	5.10	5.32	4.84	5.21	4.03	5.90	3.52	5.62	6.58	6.71	4.49	4.29	5.34	5.93	4.58	6.06	5.36	4.68	3.75
Selling, General & Admin	17.67	17.50	16.12	18.15	16.87	16.24	17.62	19.26	18.57	17.13	24.77	17.01	14.61	18.86	1.26	14.78	12.68	15.19	10.87	9.26
Total Operating Expenses	48.37	47.20	44.54	48.43	47.47	44.03	47.68	49.14	49.80	50.65	57.14	80.49	45.81	52.65	87.96	53.09	49.13	48.59	45.26	41.31
Operating Income	(5.10)	(9.34)	(9.31)	(7.12)	(6.13)	(7.66)	(11.39)	(7.79)	(7.06)	(16.27)	(28.98)	(46.72)	(11.77)	(21.91)	(58.49)	(10.29)	(2.88)	(13.59)	(6.67)	6.37
Pretax Income	(4.00)	(8.50)	(7.36)	(5.44)	(4.30)	(6.27)	(10.09)	(6.06)	(5.60)	(14.73)	(27.09)	(45.32)	(9.78)	(20.15)	(56.47)	(9.44)	(3.37)	(13.99)	(6.89)	5.93
Tax Provision	(0.15)	(0.17)	(0.24)	(0.15)	(0.15)	(0.10)	(0.33)	(0.10)	(0.01)	(0.15)	(0.53)	0.40	0.04	0.20	0.14	0.07	0.07	0.22	15.99	(6.24)
Net Income	(3.85)	(8.32)	(7.13)	(5.29)	(4.15)	(6.17)	(9.76)	(5.96)	(5.59)	(14.58)	(26.55)	(45.72)	(9.83)	(20.35)	(56.61)	(9.51)	(3.44)	(14.21)	(22.88)	12.17
Basic EPS	(0.14)	(0.30)	(0.26)	(0.20)	(0.15)	(0.25)	(0.41)	(0.25)	(0.24)	(0.62)	(1.15)	(1.97)	(0.42)	(0.88)	(2.48)	(0.42)	(0.15)	(0.62)	(1.02)	0.54
Diluted EPS	(0.14)	(0.30)	(0.26)	(0.20)	(0.15)	(0.25)	(0.41)	(0.25)	(0.24)	(0.62)	(1.15)	(1.97)	(0.42)	(0.88)	(2.48)	(0.42)	(0.15)	(0.62)	(1.00)	0.53

Cash Flow Statement

(in millions USD)

Metric	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Operating Cash Flow	2.95	(6.68)	(0.94)	2.17	4.35	(16.79)	(3.02)	6.99	6.69	(4.75)	(3.15)	2.19	4.03	(6.30)	(15.48)	(9.48)	5.53	(18.10)	6.50	(2.99)
Capital Expenditures	0.71	0.21	0.98	0.57	0.68	0.29	0.33	1.67	0.05	1.31	1.39	0.71	2.04	1.08	0.57	0.53	0.87	1.37	0.68	1.21
Free Cash Flow*	2.24	(6.89)	(1.92)	1.60	3.67	(17.08)	(3.35)	5.32	6.64	(6.06)	(4.54)	1.48	1.99	(7.38)	(16.05)	(10.02)	4.66	(19.46)	5.82	(4.21)
Investing Cash Flow	(3.13)	(1.97)	(1.52)	(0.08)	(22.57)	(2.04)	11.54	0.31	(12.38)	(13.44)	4.13	(45.79)	(0.54)	(17.11)	(6.94)	(4.75)	4.87	(4.05)	(12.38)	1.15
Financing Cash Flow	(5.62)	(2.12)	(0.19)	0.42	0.00	23.95	(0.26)	0.44	(0.20)	0.28	(0.01)	0.45	(0.03)	0.56	(0.11)	0.70	(0.10)	(0.11)	(0.03)	4.69

* Derived from reported values